Skip to content
naulon

Not checkedNot checked for notices yet.

Ficus pumila L. improves the prognosis of patients infected with HTLV-1, an RNA virus

Kenji Gonda, Koichi Suzuki, Yumi Sunabe and 2 more

Nutrition Journal · 2021

doi:10.1186/s12937-021-00672-x (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Human T-cell leukemia virus type 1 was isolated as the retrovirus to be identified in humans. Here, we focused on Ficus pumila L. as a factor that be effective against human T-cell leukemia virus type 1. The significant and novel findings is that symptoms of patients with drinking Ficus pumila L. extracts did not worsen despite a lack of aggressive pharmacotherapy against adult T-cell leukemia, a human T-cell leukemia virus type 1-associated myelopathy, or T-cell leukemia virus type 1 uveitis. Twenty-eight of the 194 inpatients who underwent showed high levels of human T-cell leukemia virus type 1. Among human T-cell leukemia virus type 1-infected patients, those who were administered Ficus pumila L . extracts had no human T-cell leukemia virus type 1-related symptoms, while those who were not administered Ficus pumila L. extracts had human T-cell leukemia virus type 1-related diseases and a significantly poorer prognosis. This suggests that the Ficus pumila L. extracts may show some utility against virus infection.

Abstract licence: CC BY-NC-ND

References10

    10 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.